NCT06678100

Brief Summary

This research study is investigating whether people with Alzheimer's disease (AD) experience more changes to swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe AD is high (85-93%), yet little is known about how swallow function evolves throughout the disease course in people with AD. The overall objective of this study is to evaluate swallowing function in adults with and without Alzheimer's disease. The investigator will also be involving the primary caregivers of individuals with Alzheimer's that are enrolled in the study to better understand the impact of swallowing impairments on the primary caregivers of those with Alzheimer's Disease. Healthy adults and individuals with Alzheimer's disease will:

  • undergo tests of cough and swallow function
  • undergo tests of grip and tongue strength
  • complete questionnaires Caregivers of individuals with Alzheimer's disease will also complete questionnaires.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Apr 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Apr 2025Feb 2028

First Submitted

Initial submission to the registry

November 5, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 7, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

April 21, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

1.8 years

First QC Date

November 5, 2024

Last Update Submit

June 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Swallowing safety

    The penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing. Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).

    During baseline visit at time of enrollment.

Secondary Outcomes (11)

  • Voluntary cough peak expiratory flow

    During baseline visit at time of enrollment

  • Grip strength

    During baseline visit at time of enrollment.

  • Tongue strength

    During baseline visit at time of enrollment.

  • Swallowing and Eating Related Fatigue Questionnaire (SERF)

    During baseline visit at time of enrollment.

  • Swallowing Related Quality of Life Questionnaire (SWAL-QOL)

    During baseline visit at time of enrollment.

  • +6 more secondary outcomes

Study Arms (2)

Healthy community dwelling adults

Healthy adults ≥ 60 years old with no prior history of neurological or respiratory diseases, swallowing impairments, or history of head and neck surgery, cancer, or radiation to the head or neck will be enrolled in this study.

Adults with Alzheimer's Disease and their caregivers

Adults with a diagnosis of Alzheimer's disease and their caregivers will be enrolled in this study.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The overall objective of this proposal is to evaluate swallow function in 80 healthy adults and 80 individuals with AD and to evaluate caregiver perceptions of swallow function and burden in 80 caregivers of individuals with AD. Thus, this study will enroll healthy adults, individuals with AD, and caregivers of individuals with AD.

You may qualify if:

  • adult ≥60 years old
  • diagnosis of AD by a neurologist (confirmed with imaging, spinal tap, behavioral testing)
  • no prior history of other neurological diseases (aside from stroke which has resolved with no current symptoms)
  • no prior history of respiratory diseases
  • no prior history of head and neck surgery/head and neck cancer/radiation to head and neck region
  • consuming some form of oral intake
  • able to follow basic directions
  • able/willing to provide consent/assent.

You may not qualify if:

  • individual \<60 years old
  • Diagnosis of another type of dementia
  • History of neurological/respiratory diseases
  • History of head and neck surgery/head and neck cancer/radiation to head and neck region
  • not consuming any oral intake
  • Unable to follow basic directions
  • Unable to provide consent based on the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC), score \<15 OR provide assent and a legal guardian provides consent.
  • care partner of an individual with AD
  • willing to complete questionnaires/participate in an interview.
  • not the primary caregiver of an individual with AD
  • unwilling to complete questionnaires/semi-structured interview
  • adult ≥60 years old
  • no prior history of neurological diseases (aside from stroke which has resolved with no current symptoms)
  • no prior history of respiratory diseases
  • \) no prior history of head and neck surgery/head and neck cancer/radiation to head and neck region 4) no prior history of swallowing difficulties based on participant report. 5) Score ≥25th percentile based on sex/age/education/race on the Montreal Cognitive Assessment (MOCA)
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

RECRUITING

MeSH Terms

Conditions

Alzheimer DiseaseCaregiver BurdenDeglutition Disorders

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersStress, PsychologicalBehavioral SymptomsBehaviorEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Central Study Contacts

Cara Donohue, PhD CCC-SLP

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Director of Medical Speech-Language Pathology

Study Record Dates

First Submitted

November 5, 2024

First Posted

November 7, 2024

Study Start

April 21, 2025

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

June 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations